PR

Pundi Rangarajan

Also known as: P N Rangarajan, P Rangarajan, Pundi N Rangarajan

Indian Institute of Science

ORCID iD 0000-0002-6536-9891

About

Yeast strains expressing Hepatitis B surface antigen developed in our laboratory are being used for commercial production of Recombinant Hepatitis B vaccines which are currently being marketed as BEVAC (monovalent), ELOVAC-B (monovalent) and ComBE FIVE and VAXTAR-5 (pentavalent).

Current research is focussed on the study of metabolism, gene regulation and signalling pathways of the methylotrophic yeast, Pichia pastoris.

Employment

  • Indian Institute of Science Professor
    1994 - Present

Education

  • Indian Institute of Science PhD
    1984 - 1989

Projects & Funding

Projects & funding information is unavailable.

Publications (80)